Shandong Jincheng Pharmaceutical Group Co Ltd
SZSE:300233
Shandong Jincheng Pharmaceutical Group Co Ltd
Interest Income Expense
Shandong Jincheng Pharmaceutical Group Co Ltd
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
Shandong Jincheng Pharmaceutical Group Co Ltd
SZSE:300233
|
Interest Income Expense
-¥873.4k
|
CAGR 3-Years
69%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
25%
|
C
|
CSPC Pharmaceutical Group Ltd
HKEX:1093
|
Interest Income Expense
¥71.6m
|
CAGR 3-Years
-48%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Interest Income Expense
¥1.1B
|
CAGR 3-Years
52%
|
CAGR 5-Years
82%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Interest Income Expense
¥134.5m
|
CAGR 3-Years
7%
|
CAGR 5-Years
4%
|
CAGR 10-Years
23%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Interest Income Expense
¥429.9m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
30%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Interest Income Expense
¥1.1B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
37%
|
See Also
What is Shandong Jincheng Pharmaceutical Group Co Ltd's Interest Income Expense?
Interest Income Expense
-873.4k
CNY
Based on the financial report for Mar 31, 2024, Shandong Jincheng Pharmaceutical Group Co Ltd's Interest Income Expense amounts to -873.4k CNY.
What is Shandong Jincheng Pharmaceutical Group Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
25%
Over the last year, the Interest Income Expense growth was 95%. The average annual Interest Income Expense growth rates for Shandong Jincheng Pharmaceutical Group Co Ltd have been 69% over the past three years , and 25% over the past ten years .